featured
Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma: A Multicenter, Randomized Phase III Trial
J. Clin. Oncol 2022 Jun 16;[EPub Ahead of Print], Y Zhang, L Chen, GQ Hu, N Zhang, XD Zhu, KY Yang, F Jin, M Shi, YP Chen, WH Hu, ZB Cheng, SY Wang, Y Tian, XC Wang, Y Sun, JG Li, WF Li, YH Li, YP Mao, GQ Zhou, R Sun, X Liu, R Guo, GX Long, SQ Liang, L Li, J Huang, JH Long, J Zang, QD Liu, L Zou, QF Su, BM Zheng, Y Xiao, Y Guo, F Han, HY Mo, JW Lv, XJ Du, C Xu, N Liu, YQ Li, FY Xie, Y Sun, J Ma, LL TangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.